Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

News releases from Geron Corporation

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Geron Corporation Reports Fourth Quarter and Annual 2007 Financial Results and Highlights
Tickers GERN
From Business Wire News Releases
Geron Ranked in Biotechnology Patent Scorecard Published in The Wall Street Journal
Tickers GERN
From Business Wire News Releases
Geron Corporation to Present at BIO CEO & Investor Conference
Tickers GERN
From Business Wire News Releases
Geron's Second U.S. Patent for Production of Pancreatic Islets from Human Embryonic Stem Cells Strengthens Company's Intellectual Property Position
Tickers GERN
From Business Wire News Releases
Dr. Thomas Okarma Resumes Direct Leadership of Geron's Oncology Drug Development Activities
Dr. Fabio Benedetti Appointed Chief Medical Officer, Oncology 
Tickers GERN
From Business Wire News Releases
Geron and Sienna Enter Into License Agreement for Cancer Diagnostics
Tickers GERN
From Business Wire News Releases
Geron Receives Milestone Payment from Merck Triggered by IND Filing for Telomerase Cancer Vaccine Candidate
Tickers GERN
From Business Wire News Releases
Geron Initiates Clinical Trial of Telomerase Inhibitor Drug in Patients with Multiple Myeloma
Human trial with GRN163L follows preclinical data showing single-agent activity against multiple myeloma cancer stem cells and cancerous plasma cells 
Tickers GERN
From Business Wire News Releases
Geron Corporation to Present at Lazard Capital Markets Healthcare Conference
Tickers GERN
From Business Wire News Releases
Recent Advances in Cellular Reprogramming
No Impact on Human Embryonic Stem Cell Therapeutic Product Development 
Tickers GERN
From Business Wire News Releases
Journal of Neuroimmunology Publishes Study Results Showing That Geron's Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
Data Indicate Short Courses of Low-Dose Immunosuppression May be Sufficient to Prevent Immune Rejection of GRNOPC1 
Tickers GERN
From Business Wire News Releases
Data Show Geron's Cell-Based Therapeutic for Spinal Cord Injury Survives and Exhibits Remyelination for at Least Nine Months Following Injection
Study Also Shows GRNOPC1 Does Not Amplify Neuropathic Pain Like Other Neural Progenitor Cells Injected Into Spinal Cord 
Tickers GERN
From Business Wire News Releases
Geron Corporation to Present at Rodman & Renshaw Healthcare Conference
Tickers GERN
From Business Wire News Releases
Geron Corporation Reports 2007 Third Quarter Financial Results and Events
Tickers GERN
From Business Wire News Releases
Geron Corporation to Present at Biotechnology Industry Organization Investor Forum
Tickers GERN
From Business Wire News Releases
Geron Corporation to Present at UBS Global Life Sciences Conference
Tickers GERN
From Business Wire News Releases
Pharmexa Loses European Patent Appeal for Broad Claims to Telomerase-Based Cancer Vaccines
Tickers GERN
From Business Wire News Releases
Geron Scientists and Collaborators Demonstrate Human Embryonic Stem Cell-Derived Cardiomyocytes Improve Heart Function When Transplanted After Myocardial Infarction
Landmark Study Published in Nature Biotechnology is First to Show Heart Repair by Cardiomyocytes Produced from Human Embryonic Stem Cells Data Demonstrate Human Cardiac Cell Survival in Infarct Zone,... 
Tickers GERN
From Business Wire News Releases
Geron Corporation Reports 2007 Second Quarter Financial Results and Events
Tickers GERN
From Business Wire News Releases
Geron Initiates Clinical Trial of Telomerase Cancer Vaccine in Patients with Acute Myelogenous Leukemia
Study Builds on Positive Data Previously Generated in Metastatic Prostate Cancer Patients Protocol Under Geron's IND is First to Employ Prime-Boost Regimen to Extend Duration of Telomerase Immunity 
Tickers GERN
From Business Wire News Releases
Geron Initiates Clinical Trial of Telomerase Inhibitor Drug in Combination With Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer
Third Clinical Trial Program for 163L -- First Clinical Use in Combination Chemotherapy Ongoing Studies in CLL and Solid Tumors Continue to Accrue Patients 
Tickers GERN
From Business Wire News Releases
Geron Corporation to Host Analyst and Investor Meeting in New York City on July 17, 2007
- Event to be Webcast on Geron's Website - 
Tickers GERN
From Business Wire News Releases
Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for Heart Failu
Company's Second Cell Type for Clinical Development - Cardiomyocytes for Treatment of Heart Failure - is Subject of Feature Presentation at ISSCR Annual Meeting Other Presentations Document Continued... 
Tickers GERN
From Business Wire News Releases
Geron Increases Stake in TA Therapeutics Joint Venture
Joint Venture Company is Working Toward Filing of IND for Small Molecule Compound to Treat HIV/AIDS 
Tickers GERN
From Business Wire News Releases
Geron Corporation to Present at Needham & Company Biotechnology and Medical Technology Conference
Tickers GERN
From Business Wire News Releases
Geron's Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
Data Presented at Pan Pacific Lymphoma Conference Support Continued Dose Escalation in Ongoing Chronic Lymphocytic Leukemia Trial New Studies in Multiple Myeloma and Non-Small Cell Lung Cancer to Start... 
Tickers GERN
From Business Wire News Releases
Research Indicates Geron's Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
Study Findings Could Mean Significantly Lower Doses and/or Shorter Courses of Immunosuppression for Patients Treated with GRNOPC1 
Tickers GERN
From Business Wire News Releases
Geron Corporation to Present at Banc of America Health Care Conference
Tickers GERN
From Business Wire News Releases
Geron Scientists and Collaborators Differentiate Human Embryonic Stem Cells Into Insulin-Producing Islet-Like Clusters
Studies Demonstrate Feasibility of Producing Therapeutic Cells From hESCs for Treatment of Diabetes 
Tickers GERN
From Business Wire News Releases
Geron Corporation to Present at UBS Global Generic & Specialty Pharmaceuticals Conference
Tickers GERN
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback